Report

1 Executive Summary
2 Research Scope & Segmentation
2.1 Research Objectives
2.2 Limitations & Assumptions
2.3 Market Scope & Segmentation
2.4 Currency & Pricing Considered
3 Market Opportunity Assessment
3.1 Emerging Regions / Countries
3.2 Emerging Companies
3.3 Emerging Applications / End Use
4 Market Trends
4.1 Drivers
4.2 Market Warning Factors
4.3 Latest Macro Economic Indicators
4.4 Geopolitical Impact
4.5 Technology Factors
5 Market Assessment
5.1 Porters Five Forces Analysis
5.2 Value Chain Analysis
6 Global Mesenchymal Stem Cells Market Size Analysis
6.1 By Products and Services
6.1.1
6.1.1.1 Cells and Cell Lines
6.1.1.2 Kits, Media, and Reagents
6.1.2 Services
6.2 By Workflow
6.2.1 Cell Sourcing and Isolation
6.2.2 Culture and Cryopreservation
6.2.3 Differentiation
6.2.4 Characterization
6.3 By Type
6.3.1 Autologous
6.3.2 Allogeneic
6.4 By Source of Isolation
6.4.1 Bone Marrow
6.4.2 Cord Blood
6.4.3 Peripheral Blood
6.4.4 Fallopian Tube
6.4.5 Fetal Liver
6.4.6 Lung
6.4.7 Adipose Tissues
6.5 By Indication
6.5.1 Bone And Cartilage Repair
6.5.2 Cardiovascular Disease
6.5.3 Inflammatory And Immunological Diseases
6.5.4 Liver Diseases
6.5.5 Cancer
6.5.6 GvHD
6.6 By Application
6.6.1 Disease Modelling
6.6.2 Drug Development and Discovery
6.6.3 Stem Cell Banking
6.6.4 Tissue Engineering
6.6.5 Toxicology Studies
7 North America Market Analysis
7.1 By Products and Services
7.1.1
7.1.1.1 Cells and Cell Lines
7.1.1.2 Kits, Media, and Reagents
7.1.2 Services
7.2 By Workflow
7.2.1 Cell Sourcing and Isolation
7.2.2 Culture and Cryopreservation
7.2.3 Differentiation
7.2.4 Characterization
7.3 By Type
7.3.1 Autologous
7.3.2 Allogeneic
7.4 By Source of Isolation
7.4.1 Bone Marrow
7.4.2 Cord Blood
7.4.3 Peripheral Blood
7.4.4 Fallopian Tube
7.4.5 Fetal Liver
7.4.6 Lung
7.4.7 Adipose Tissues
7.5 By Indication
7.5.1 Bone And Cartilage Repair
7.5.2 Cardiovascular Disease
7.5.3 Inflammatory And Immunological Diseases
7.5.4 Liver Diseases
7.5.5 Cancer
7.5.6 GvHD
7.6 By Application
7.6.1 Disease Modelling
7.6.2 Drug Development and Discovery
7.6.3 Stem Cell Banking
7.6.4 Tissue Engineering
7.6.5 Toxicology Studies
7.6 U.S.
7.7 Canada
8 Europe Market Analysis
8.1 By Products and Services
8.1.1
8.1.1.1 Cells and Cell Lines
8.1.1.2 Kits, Media, and Reagents
8.1.2 Services
8.2 By Workflow
8.2.1 Cell Sourcing and Isolation
8.2.2 Culture and Cryopreservation
8.2.3 Differentiation
8.2.4 Characterization
8.3 By Type
8.3.1 Autologous
8.3.2 Allogeneic
8.4 By Source of Isolation
8.4.1 Bone Marrow
8.4.2 Cord Blood
8.4.3 Peripheral Blood
8.4.4 Fallopian Tube
8.4.5 Fetal Liver
8.4.6 Lung
8.4.7 Adipose Tissues
8.5 By Indication
8.5.1 Bone And Cartilage Repair
8.5.2 Cardiovascular Disease
8.5.3 Inflammatory And Immunological Diseases
8.5.4 Liver Diseases
8.5.5 Cancer
8.5.6 GvHD
8.6 By Application
8.6.1 Disease Modelling
8.6.2 Drug Development and Discovery
8.6.3 Stem Cell Banking
8.6.4 Tissue Engineering
8.6.5 Toxicology Studies
8.6 U.K.
8.7 Germany
8.8 France
8.9 Spain
8.10 Italy
8.11 Russia
8.12 Nordic
8.13 Benelux
8.14 Rest of Europe
9 APAC Market Analysis
9.1 By Products and Services
9.1.1
9.1.1.1 Cells and Cell Lines
9.1.1.2 Kits, Media, and Reagents
9.1.2 Services
9.2 By Workflow
9.2.1 Cell Sourcing and Isolation
9.2.2 Culture and Cryopreservation
9.2.3 Differentiation
9.2.4 Characterization
9.3 By Type
9.3.1 Autologous
9.3.2 Allogeneic
9.4 By Source of Isolation
9.4.1 Bone Marrow
9.4.2 Cord Blood
9.4.3 Peripheral Blood
9.4.4 Fallopian Tube
9.4.5 Fetal Liver
9.4.6 Lung
9.4.7 Adipose Tissues
9.5 By Indication
9.5.1 Bone And Cartilage Repair
9.5.2 Cardiovascular Disease
9.5.3 Inflammatory And Immunological Diseases
9.5.4 Liver Diseases
9.5.5 Cancer
9.5.6 GvHD
9.6 By Application
9.6.1 Disease Modelling
9.6.2 Drug Development and Discovery
9.6.3 Stem Cell Banking
9.6.4 Tissue Engineering
9.6.5 Toxicology Studies
9.6 China
9.7 Korea
9.8 Japan
9.9 India
9.10 Australia
9.11 Singapore
9.12 Taiwan
9.13 South East Asia
9.14 Rest of Asia-Pacific
10 Middle East and Africa Market Analysis
10.1 By Products and Services
10.1.1
10.1.1.1 Cells and Cell Lines
10.1.1.2 Kits, Media, and Reagents
10.1.2 Services
10.2 By Workflow
10.2.1 Cell Sourcing and Isolation
10.2.2 Culture and Cryopreservation
10.2.3 Differentiation
10.2.4 Characterization
10.3 By Type
10.3.1 Autologous
10.3.2 Allogeneic
10.4 By Source of Isolation
10.4.1 Bone Marrow
10.4.2 Cord Blood
10.4.3 Peripheral Blood
10.4.4 Fallopian Tube
10.4.5 Fetal Liver
10.4.6 Lung
10.4.7 Adipose Tissues
10.5 By Indication
10.5.1 Bone And Cartilage Repair
10.5.2 Cardiovascular Disease
10.5.3 Inflammatory And Immunological Diseases
10.5.4 Liver Diseases
10.5.5 Cancer
10.5.6 GvHD
10.6 By Application
10.6.1 Disease Modelling
10.6.2 Drug Development and Discovery
10.6.3 Stem Cell Banking
10.6.4 Tissue Engineering
10.6.5 Toxicology Studies
10.6 UAE
10.7 Turkey
10.8 Saudi Arabia
10.9 South Africa
10.10 Egypt
10.11 Nigeria
10.12 Rest of MEA
11 LATAM Market Analysis
11.1 By Products and Services
11.1.1
11.1.1.1 Cells and Cell Lines
11.1.1.2 Kits, Media, and Reagents
11.1.2 Services
11.2 By Workflow
11.2.1 Cell Sourcing and Isolation
11.2.2 Culture and Cryopreservation
11.2.3 Differentiation
11.2.4 Characterization
11.3 By Type
11.3.1 Autologous
11.3.2 Allogeneic
11.4 By Source of Isolation
11.4.1 Bone Marrow
11.4.2 Cord Blood
11.4.3 Peripheral Blood
11.4.4 Fallopian Tube
11.4.5 Fetal Liver
11.4.6 Lung
11.4.7 Adipose Tissues
11.5 By Indication
11.5.1 Bone And Cartilage Repair
11.5.2 Cardiovascular Disease
11.5.3 Inflammatory And Immunological Diseases
11.5.4 Liver Diseases
11.5.5 Cancer
11.5.6 GvHD
11.6 By Application
11.6.1 Disease Modelling
11.6.2 Drug Development and Discovery
11.6.3 Stem Cell Banking
11.6.4 Tissue Engineering
11.6.5 Toxicology Studies
11.6 Brazil
11.7 Mexico
11.8 Argentina
11.9 Chile
11.10 Colombia
11.11 Rest of LATAM
12 Competitive Landscape
12.1 Global Mesenchymal Stem Cells Market Share By Players
12.2 M & A Agreements & Collaboration Analysis
13 Market Players Assessment
13.1 American International Industries (GIGI)
13.1.1 Overview
13.1.2 Business Information
13.1.3 Revenue
13.1.4 ASP
13.1.5 Swot Analysis
13.1.6 Recent Developments
13.2 Cell Applications, Inc.
13.3 Axol Biosciences Ltd.
13.4 Cytori Therapeutics Inc
13.5 STEMCELL Technologies
13.6 Cyagen Biosciences.
13.7 Celprogen Inc
13.8 BrainStorm Cell Limited.
13.9 Stemedica Cell Technologies Inc
13.10 Merck KGaA (MilliporeSigma)
13.11 Lonza
13.12 PromoCell GmbH
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.1.1 Major secondary sources
14.1.1.2 Key data from secondary sources
14.1.2 Primary Data
14.1.2.1 Key data from primary sources
14.1.2.2 Breakdown of primaries
14.1.3 Secondary And Primary Research
14.1.3.1 Key industry insights
14.2 Market Size Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach
14.2.3 Market Projection
14.3 Research Assumptions
14.3.1 Assumptions
14.4 Limitations
14.5 Risk Assessment
15 Appendix
15.1 Discussion Guide
15.2 Customization Options
15.3 Related Reports
16 Disclaimer